AYGEN, B. Et Al. 2018. Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.3 , 259-269.

AYGEN, B., DEMİR, A. M., GÜMÜŞ, M., Karabay, O., Kaymakoglu, S., KÖKSAL, A. Ş., ... Koksal, I.(2018). Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report. TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.3, 259-269.

AYGEN, BİLGEHAN Et Al. "Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report," TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.3, 259-269, 2018

AYGEN, BİLGEHAN Et Al. "Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.3, pp.259-269, 2018

AYGEN, B. Et Al. (2018) . "Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report." TURKISH JOURNAL OF GASTROENTEROLOGY , vol.29, no.3, pp.259-269.

@article{article, author={BİLGEHAN AYGEN Et Al. }, title={Immunosuppressive therapy and the risk of hepatitis B reactivation: Consensus report}, journal={TURKISH JOURNAL OF GASTROENTEROLOGY}, year=2018, pages={259-269} }